Financial SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results byJosh SandbergAugust 13, 2024
Financial SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) byJosh SandbergApril 10, 2024
Biologics Financial SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer byTim AllenApril 1, 2024
Financial Top Stories SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders byJosh SandbergFebruary 23, 2024
Financial SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA) byJosh SandbergJanuary 22, 2024
Financial SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023 byJosh SandbergJanuary 10, 2024
Financial SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results byJosh SandbergNovember 9, 2023
Financial SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023 byJosh SandbergOctober 10, 2023
